STOCKHOLM, Aug. 22, 2019 /PRNewswire/ -- AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its interim report for the January - June 2019 is now available on the company's website:

LUND, Sweden, Aug. 22, 2019 /PRNewswire/ -- "We are executing according to plan. Our lead candidate BI-1206 has shown encouraging initial data in hematological cancers, and has now also entered clinical trials in solid cancer," Martin Welschof, CEO BioInventFinancial informationSecond quarter 2019

STOCKHOLM, Aug. 22, 2019 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi

CORK, Ireland, Aug. 22, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) have announced positive top-line results from the Phase 3 ATLAS-2M study of the investigational, long-acting two-drug injectable regimen of its rilpivirine and ViiV Healthcare's cabotegravir for the treatment of HIV. The study achieved its primary

NEWARK, N.J., Aug. 22, 2019 /PRNewswire/ -- AGS Health (AGS), a leading provider of technology-enabled healthcare solutions to US healthcare providers, announced today the appointment of Ms. Patrice Wolfe as the company's new Chief Executive Officer (CEO). Patrice has in-depth expertise in building and scaling healthcare

OSLO, Norway, Aug. 22, 2019 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces its results for the second quarter and first half 2019. A presentation by the company's senior management team will take place today in Oslo at 08:30 CEST, see details below. Eduardo

State-of-the-art, 14,000 square foot GMP compliant cannabis extraction lab and ISO 17025 compliant cannabis testing lab includes full capabilities in Ultra high and High performance liquid chromatography ("UHPLC" & "HPLC") technology, gas chromatography, stability testing, microbiology and heavy metals testingPhysical chemical cannabis testing lab has a capacity of up to 70 daily UHPLC

SUZHOU, China, Aug. 21, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that it has entered into a licensing agreement with Eli Lilly and Company (Lilly) for the development and potential commercialization of oxyntomodulin analog

CHARLOTTE, N.C., Aug. 21, 2019 /PRNewswire/ -- Joerns Healthcare, a leading durable medical equipment manufacturer and supplier, announced today that the financial reorganization for the company and its domestic subsidiaries is complete following the effectiveness and consummation of Joerns' court-approved plan of reorganization. The reorganization reduced the com

PLYMOUTH, Minn., Aug. 21, 2019 /PRNewswire/ -- The Hazelden Betty Ford Foundation announced today that its renowned Children's Progra